Advertisements


Buy Tirzepatide peptide powder from reliable polypeptide supplier-Polypeptide.ltd
Price: | US$ 300 / Box |
---|---|
Minimum Order: | 1 box |
Payment Terms: | TT,Virtual currency |
Port of Export: |
Product Details
Model No.: | Brand Name: |
---|
Certification: | |
---|---|
Specification: | Tirzepatide’s weight loss efficacy is supported by clinical trials. In the SURMOUNT-1 and SURMOUNT-2 trials, participants experienced substantial weight loss, with those on the 15mg dose achieving an average of 13.4% reduction in body weight. Moreover, a higher percentage of individuals taking Tirzepatide reached clinically significant weight loss milestones compared to the placebo group. |
Packaging & Delivery
Packaging: | |
---|---|
Delivery/Lead Time: | |
Production Capacity: | Provide customization |
Product Description
Tirzepatide is a novel, once-weekly injectable medication being developed by Eli Lilly and Company for the treatment of type 2 diabetes. It is marketed under the brand name Mounjaro,received FDA approval on May 13, 2022. Tirzepatide acts as a dual agonist for GIP (glucose-dependent insulinotropic polypeptide) and GLP-1 (glucagon-like peptide-1) receptors. GIP stimulates insulin release and inhibits glucagon, while GLP-1 enhances insulin secretion, suppresses glucagon, and promotes fullness. Tirzepatide’s combined action optimizes blood sugar control, as insulin uptake increases and glucose production decreases. The synergy of GIP and GLP-1 mechanisms may lead to improved glycemic management and weight loss. Tirzepatide’s innovative approach harnesses the benefits of both hormones, making it a promising therapeutic option for individuals with type 2 diabetes and obesity, addressing multiple aspects of metabolic regulation. According to SURMOUNT-2 study, tirzepatide achieved up to 15.7% weight loss in adults with obesity or overweight and type 2 diabetes.
If you need to buy Tirzepatide, you need to find a reliable and reputable seller. Polypeptide.ltd is a manufacturer in China who focuses on the research of peptide products, it can provide competitive prices for bulk orders. You can buy pharmaceutical grade products from Polypeptide.ltd.
Tirzepatide peptide benefits | What Tirzepatide peptide uses for?
Peptide Tirzepatide is primarily used for the management of two key health conditions: type 2 diabetes mellitus and obesity. It offers benefits in both of these areas due to its unique mechanism of action as a dual agonist of GLP-1 (glucagon-like peptide-1) and GIP (glucose-dependent insulinotropic polypeptide) receptors. Here are its main uses:
Tirzepatide for Type 2 Diabetes Management
Tirzepatide is FDA-approved as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus. It helps lower blood sugar levels by enhancing insulin secretion and sensitivity, thereby supporting better glucose regulation.
Tirzepatide for Weight Loss
Tirzepatide has shown significant potential for weight reduction. Clinical trials have demonstrated substantial weight loss in individuals who are obese or overweight, making it a potential option for those seeking effective weight management.
Tirzepatide for Cardioprotection (Under Investigation)
Ongoing research is exploring the potential cardioprotective effects of Tirzepatide. Studies are investigating whether its influence on lipoprotein profiles and other factors may contribute to reducing the risk of cardiovascular diseases in individuals with type 2 diabetes.
Other Potential Applications (Under Investigation)
Research is also underway to explore the broader impact of Tirzepatide in conditions beyond diabetes and obesity. This includes its potential role in heart failure with preserved ejection fraction (HFpEF), obstructive sleep apnea (OSA), non-alcoholic steatohepatitis (NASH), chronic kidney disease (CKD), and obesity-related morbidity and mortality. Scientists who want to buy Tirzepatide powder to do the research, make sure buy it from a reliable peptide manufacturer such as Polypeptide.Ltd.
Tirzepatide offers a range of notable benefits. Tirzepatide’s unique combination of addressing both diabetes and obesity, along with its potential cardiovascular benefits, positions it as a promising therapeutic option for individuals seeking comprehensive health management.
Tirzepatide dosage – How to use Tirzepatide petide?
Polypeptide.ltd as a Tirzepatide supplier. We only good at producing high quality Tirzepatide powder. The Tirzepatide powder dosage and administration information provided here is for informational purposes only and should not be considered as medical advice. The dosing of tirzepatide can vary based on its intended use for type 2 diabetes and weight loss. Based on multiple studies, here is a general tirzepatide dosage guide:
Tirzepatide dosage for Type 2 Diabetes
Tirzepatide(Mounjaro) is used as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus. The dosing typically follows this pattern:
Initial Dose: 2.5 mg subcutaneous injection once a week for 4 weeks.
Maintenance Dose: Increase to 5 mg subcutaneous injection once a week after the initial 4 weeks.
Titration: If additional glycemic control is needed, the dose can be increased in 2.5 mg increments after at least 4 weeks at the current dose.
Maximum Dose: The maximum recommended dose is 15 mg subcutaneous injection once a week.
Please note that the initial 2.5 mg dose is for treatment initiation and is not effective for glycemic control. You will need to adjust your dosage based on your response and needs.
Tirzepatide dosage for Weight Loss
Tirzepatide has been shown to help lose weight in overweight patients. The dosing for weight loss may be different and can be informed by clinical trials such as SURMOUNT-1 and SURMOUNT-2. Polypeptide.ltd as Tizepatide powder manufacturer don’t teach how to use Tirzepatide. But a potential weight loss protocol could be:
Initial Dose: 2.5 mg subcutaneous injection once a week for the first four weeks.
Progressive Increase: Increase the dose to 5 mg weekly in weeks 5-8, 7.5 mg weekly in weeks 9-12, and 10 mg weekly in weeks 13-16.
Further Adjustment: Depending on individual response and tolerance, consider increasing to 12.5 mg weekly in weeks 17-20, and up to a maximum dose of 15 mg weekly from week 21 onwards.
Frequency and Duration: Administer once-weekly subcutaneous injections, and studies using this protocol have lasted 24-72 weeks.
It’s essential to consult your healthcare provider before making any changes to your medication dosage. This guide is a general overview and should not replace personalized medical advice. Your healthcare provider will determine the most appropriate dosing regimen for your specific condition and needs.
Contact information
Official website:https://*/product/tirzepatide/
Phone number:+86 15218708159
Email:Lynn at polypeptide.ltd
SUPPLIER PROFILE
|
|||
---|---|---|---|
Company: | Polypeptide.ltd | ||
City/State | shenzhen, China | Country: |
China ![]() |
Business Type: | Export - Manufacturer / Trading Company | Established: | NA |
Member Since: | 2023 | Contact Person | Lynn he |
SUPPLIER PROFILE
City/State/Country -
shenzhen, China
China 

Business Type -
Export - Manufacturer / Trading Company
Established -
NA
Member Since -
2023
Contact Person -
Lynn he